There are 2949 resources available
Live Q&A - 18 September 2020 - 15:30-16:00
Presenter: Pilar Garrido
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Welcome and Introduction: Evolution of patient care in HER2-positive eBC
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Clinical perspectives on a patient with advanced NSCLC
Presenter: Gilad Vainer
Session: Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team
Resources:
Webcast
Continuing a patient's journey after pCR: Evidence-based decision–making
Presenter: Christian Jackisch
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
If tissue is the issue, think blood
Presenter: Natalie Cook
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Learning from real-world patients, in real-life conditions
Presenter: Kenneth Kehl
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Looking at where personalised healthcare has become reality
Presenter: Emile Voest
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Conclusion
Presenter: Emile Voest
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Welcome and introduction
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Treatments After Progression in the First-Line of Non-Mutated NSCLC Adenocarcinoma
Presenter: Silvia Novello
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast